Top

Published in:

01-06-2013 | Topic Review

Primary intracranial germ-cell tumors in adults: a practical review

Authors: Jacoline E. C. Bromberg, Brigitta G. Baumert, Filip de Vos, Johanna M. M. Gijtenbeek, Erkan Kurt, Anneke M. Westermann, Pieter Wesseling

Published in: Journal of Neuro-Oncology | Issue 2/2013

Abstract

Primary intracranial germ-cell tumors are rare tumors primarily of adolescence, and literature on this disease in adults is scarce. The available evidence on intracranial germ-cell tumors is reviewed with a focus on adult patients whenever possible, and used to make suggestions for diagnosis and treatment. Diagnostic and treatment algorithms were developed to provide an evidence-based backbone to base treatment on in adult patients with a (suspected) primary intracranial germ-cell tumor.

McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL (2012) Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro-Oncology 14:1194–1200PubMedCrossRef

Rosenblum MK (2007) Germ cell tumors. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the centrel nervous system. International Agency for Research on Cancer, Lyon, pp 198–204

Matsutani M (2005) Germ cell tumors. In: Berger MS, Prados MD (eds) Textbook of neuro-oncology. Elsevier, Philadelphia, pp 310–320CrossRef

Kamoshima Y, Sawamura Y (2010) Update on current standard treatments in central nervous system germ cell tumors. Curr Opin Neurol 23:571–575PubMedCrossRef

Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, Seto T (1997) Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 86:446–455PubMedCrossRef

Weksberg DC, Shibamoto Y, Paulino AC (2012) Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys 82:1341–1351PubMedCrossRef

Crawford JR, Santi MR, Vezina G, Myseros JS, Keating RF, LaFond DA, Rood BR, MacDonald TJ, Packer RJ (2007) CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis. Neurology 68:1668–1673PubMedCrossRef

Jorsal T, Rorth M (2012) Intracranial germ cell tumours. A review with special reference to endocrine manifestations. Acta Oncol 51:3–9PubMedCrossRef

Blakeley JO, Grossman SA (2006) Management of pineal region tumors. Curr Treat Options Oncol 7:505–516PubMedCrossRef

10.

Sonoda Y, Kumabe T, Sugiyama S, Kanamori M, Yamashita Y, Saito R, Ariga H, Takai Y, Tominaga T (2008) Germ cell tumors in the basal ganglia: problems of early diagnosis and treatment. J Neurosurg Pediatr 2:118–124PubMedCrossRef

11.

Ogino H, Shibamoto Y, Takanaka T, Suzuki K, Ishihara S, Yamada T, Sugie C, Nomoto Y, Mimura M (2005) CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome. Int J Radiat Oncol Biol Phys 62:803–808PubMedCrossRef

12.

Kim A, Ji L, Balmaceda C, Diez B, Kellie SJ, Dunkel IJ, Gardner SL, Sposto R, Finlay JL (2008) The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors. Pediatr Blood Cancer 51:768–773PubMedCrossRef

13.

Calaminus G, Bamberg M, Harms D, Jurgens H, Kortmann RD, Sorensen N, Wiestler OD, Gobel U (2005) AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics 36:71–77PubMedCrossRef

14.

Allen J, Chacko J, Donahue B, Dhall G, Kretschmar C, Jakacki R, Holmes E, Pollack I (2012) Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma. Pediatr Blood Cancer 59:1180–1182PubMedCrossRef

15.

Tian C, Shi Q, Xiao G, Pu C, Huang X, Yu S, Zhang J (2011) CSF and serum hCG in patients without gestational and neoplastic hCG-secretion. Scand J Clin Lab Invest 71:264–268PubMedCrossRef

16.

Weiner HL, Finlay JL (1999) Surgery in the management of primary intracranial germ cell tumors. Childs Nerv Syst 15:770–773PubMedCrossRef

17.

Lafay-Cousin L, Millar BA, Mabbott D, Spiegler B, Drake J, Bartels U, Huang A, Bouffet E (2006) Limited-field radiation for bifocal germinoma. Int J Radiat Oncol Biol Phys 65:486–492PubMedCrossRef

18.

Sawamura Y, de Tribolet N, Ishii N, Abe H (1997) Management of primary intracranial germinomas: diagnostic surgery or radical resection? J Neurosurg 87:262–266PubMedCrossRef

19.

Czech T, Nicholson J, Frappaz D, Kortmann RD, Alapetite C, Garre ML, Ricardi U, Saran FH, Calaminus G (2012) Patients with intracranial non-germinomatous germ cell tumours (NGGCT) benefit from delayed surgery after neoadjuvant chemotherapy. Final results of SIOP CNS GCT 96. p i52

20.

Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL (2004) Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol. J Clin Oncol 22:846–853PubMedCrossRef

21.

Souweidane MM, Krieger MD, Weiner HL, Finlay JL (2010) Surgical management of primary central nervous system germ cell tumors: proceedings from the Second International Symposium on Central Nervous System Germ Cell Tumors. J Neurosurg Pediatr 6:125–130PubMedCrossRef

22.

Luther N, Edgar MA, Dunkel IJ, Souweidane MM (2006) Correlation of endoscopic biopsy with tumor marker status in primary intracranial germ cell tumors. J Neurooncol 79:45–50PubMedCrossRef

23.

Shono T, Natori Y, Morioka T, Torisu R, Mizoguchi M, Nagata S, Suzuki SO, Iwaki T, Inamura T, Fukui M, Oka K, Sasaki T (2007) Results of a long-term follow-up after neuroendoscopic biopsy procedure and third ventriculostomy in patients with intracranial germinomas. J Neurosurg 107:193–198PubMed

24.

Friedman JA, Lynch JJ, Buckner JC, Scheithauer BW, Raffel C (2001) Management of malignant pineal germ cell tumors with residual mature teratoma. Neurosurgery 48:518–522PubMedCrossRef

25.

O’Callaghan AM, Katapodis O, Ellison DW, Theaker JM, Mead GM (1997) The growing teratoma syndrome in a nongerminomatous germ cell tumor of the pineal gland: a case report and review. Cancer 80:942–947PubMedCrossRef

26.

Foote M, Millar BA, Sahgal A, Menard C, Payne D, Mason W, Laperriere N (2010) Clinical outcomes of adult patients with primary intracranial germinomas treated with low-dose craniospinal radiotherapy and local boost. J Neurooncol 100:459–463PubMedCrossRef

27.

Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, Gobel U (1999) Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 17:2585–2592PubMed

28.

Maity A, Shu HK, Janss A, Belasco JB, Rorke L, Phillips PC, Sutton LN, Goldwein JW (2004) Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas: twenty-five years’ experience in a single center. Int J Radiat Oncol Biol Phys 58:1165–1170PubMedCrossRef

29.

Schoenfeld GO, Amdur RJ, Schmalfuss IM, Morris CG, Keole SR, Mendenhall WM, Marcus RB Jr (2006) Low-dose prophylactic craniospinal radiotherapy for intracranial germinoma. Int J Radiat Oncol Biol Phys 65:481–485PubMedCrossRef

30.

Shikama N, Ogawa K, Tanaka S, Toita T, Nakamura K, Uno T, Ohnishi H, Itami J, Tada T, Saeki N (2005) Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma: a multiinstitutional, retrospective review of 180 patients. Cancer 104:126–134PubMedCrossRef

31.

Nguyen QN, Chang EL, Allen PK, Maor MH, Ater JL, Mahajan A, Wolff JE, Weinberg JS, Woo SY (2006) Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer 107:2228–2236PubMedCrossRef

32.

Haas-Kogan DA, Missett BT, Wara WM, Donaldson SS, Lamborn KR, Prados MD, Fisher PG, Huhn SL, Fisch BM, Berger MS, Le QT (2003) Radiation therapy for intracranial germ cell tumors. Int J Radiat Oncol Biol Phys 56:511–518PubMedCrossRef

33.

Ogawa K, Shikama N, Toita T, Nakamura K, Uno T, Onishi H, Itami J, Kakinohana Y, Kinjo T, Yoshii Y, Ito H, Murayama S (2004) Long-term results of radiotherapy for intracranial germinoma: a multi-institutional retrospective review of 126 patients. Int J Radiat Oncol Biol Phys 58:705–713PubMedCrossRef

34.

Wolden SL, Wara WM, Larson DA, Prados MD, Edwards MS, Sneed PK (1995) Radiation therapy for primary intracranial germ-cell tumors. Int J Radiat Oncol Biol Phys 32:943–949PubMedCrossRef

35.

Alapetite C, Brisse H, Patte C, Raquin MA, Gaboriaud G, Carrie C, Habrand JL, Thiesse P, Cuilliere JC, Bernier V, Ben-Hassel M, Frappaz D, Baranzelli MC, Bouffet E (2010) Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro-Oncology 12:1318–1325PubMed

36.

Shibamoto Y, Takahashi M, Abe M (1994) Reduction of the radiation dose for intracranial germinoma: a prospective study. Br J Cancer 70:984–989PubMedCrossRef

37.

Aoyama H, Shirato H, Ikeda J, Fujieda K, Miyasaka K, Sawamura Y (2002) Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J Clin Oncol 20:857–865PubMedCrossRef

38.

Calaminus G, Frappaz D, Kortmann RD, Alapetite C, Garre ML, Ricardio U, Saran FH, Nicholson J (2012) Risk adapted irradiation is feasible in intracranial non-germinomatous germ cell tumours (NGGCT): final results of SIOP CNS GCT 96. p i51

39.

Buckner JC, Peethambaram PP, Smithson WA, Groover RV, Schomberg PJ, Kimmel DW, Raffel C, O’Fallon JR, Neglia J, Shaw EG (1999) Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J Clin Oncol 17:933–940PubMed

40.

Jennings MT, Gelman R, Hochberg F (1985) Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 63:155–167PubMedCrossRef

41.

Matsutani M (2001) Combined chemotherapy and radiation therapy for CNS germ cell tumors–the Japanese experience. J Neurooncol 54:311–316PubMedCrossRef

42.

Robertson PL, DaRosso RC, Allen JC (1997) Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neurooncol 32:71–80PubMedCrossRef

43.

Calaminus G, Bamberg M, Jurgens H, Kortmann RD, Sorensen N, Wiestler OD, Gobel U (2004) Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr 216:141–149PubMedCrossRef

44.

Kim JW, Kim WC, Cho JH, Kim DS, Shim KW, Lyu CJ, Won SC, Suh CO (2012) A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors. Int J Radiat Oncol Biol Phys 84(3):625–631PubMedCrossRef

45.

Sands SA, Kellie SJ, Davidow AL, Diez B, Villablanca J, Weiner HL, Pietanza MC, Balmaceda C, Finlay JL (2001) Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study. Neuro-Oncology 3:174–183PubMed

46.

Bouffet E, Baranzelli MC, Patte C, Portas M, Edan C, Chastagner P, Mechinaud-Lacroix F, Kalifa C (1999) Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Societe Francaise d’Oncologie Pediatrique. Br J Cancer 79:1199–1204PubMedCrossRef

47.

Eom KY, Kim IH, Park CI, Kim HJ, Kim JH, Kim K, Kim SK, Wang KC, Cho BG, Jung HW, Heo DS, Kang HJ, Shin HY, Ahn HS (2008) Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed. Int J Radiat Oncol Biol Phys 71:667–671PubMedCrossRef

48.

Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL (2004) Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatr Blood Cancer 43:126–133PubMedCrossRef

49.

Mabbott DJ, Monsalves E, Spiegler BJ, Bartels U, Janzen L, Guger S, Laperriere N, Andrews N, Bouffet E (2011) Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood. Cancer 117:5402–5411PubMedCrossRef

50.

Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S, Finlay JL (1996) Chemotherapy without irradiation—a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The first International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 14:2908–2915PubMed

51.

da Silva NS, Cappellano AM, Diez B, Cavalheiro S, Gardner S, Wisoff J, Kellie S, Parker R, Garvin J, Finlay J (2010) Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study. Pediatr Blood Cancer 54:377–383PubMedCrossRef

53.

Matsutani M (2012) Multi-institutional, prospective phase 2 study for primary intracranial germ cell tumors. German Medical Science GMS Publishing House, Düsseldorf, p i51

54.

Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, Bajorin DF, Lara PN Jr, Einhorn L, Mazumdar M, Bosl GJ (2007) Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 25:247–256PubMedCrossRef

55.

Daugaard G, Skoneczna I, Aass N, De WR, De SM, Dumez H, Marreaud S, Collette L, Lluch JR, Bokemeyer C, Schmoll HJ (2011) A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974). Ann Oncol 22:1054–1061PubMedCrossRef

56.

Modak S, Gardner S, Dunkel IJ, Balmaceda C, Rosenblum MK, Miller DC, Halpern S, Finlay JL (2004) Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol 22:1934–1943PubMedCrossRef

57.

Simonelli M, Rosti G, Banna GL, Pedrazzoli P (2012) Intensified chemotherapy with stem-cell rescue in germ-cell tumors. Ann Oncol 23:815–822PubMedCrossRef

58.

Ogawa K, Toita T, Nakamura K, Uno T, Onishi H, Itami J, Shikama N, Saeki N, Yoshii Y, Murayama S (2003) Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients. Cancer 98:369–376PubMedCrossRef

59.

Kamoshima Y, Sawamura Y, Ikeda J, Shirato H, Aoyama H (2008) Late recurrence and salvage therapy of CNS germinomas. J Neurooncol 90:205–211PubMedCrossRef

60.

Inamura T, Nishio S, Ikezaki K, Fukui M (1999) Human chorionic gonadotrophin in CSF, not serum, predicts outcome in germinoma. J Neurol Neurosurg Psychiatry 66:654–657PubMedCrossRef

Title: Primary intracranial germ-cell tumors in adults: a practical review
Authors: Jacoline E. C. Bromberg
Brigitta G. Baumert
Filip de Vos
Johanna M. M. Gijtenbeek
Erkan Kurt
Anneke M. Westermann
Pieter Wesseling
Publication date: 01-06-2013
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2013
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-013-1114-6

At a glance: The STEP trials

Springer Medicine

Primary intracranial germ-cell tumors in adults: a practical review

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression

Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution

The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience

Unclear standard of care for pediatric high grade glioma patients

‘Elderly’ patients with newly diagnosed glioblastoma deserve optimal care

Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma